PTPA and B-cell chronic lymphocytic leukemia: It was reported that COG449, a peptide that binds antagonistically to SET, increased cellular PP2A activity, decreased Mcl-1 expression, and displayed selective cytotoxicity for CLL and NHL cells in vitro [167].